Search Results - "Menard, A.L."

Impact of Cytogenetics on Outcome after Allogeneic Transplantation for Myelodysplastic Syndrome or Post MDS Secundary Myeloid Leukemia by Menard, A.L, Marcq, B, Stamatoullas, A, Contentin, N, Lebreton, P, Rezine, I, Penther, D, Etancelin, P, Lepretre, S, Lenain, P, Lanic, H, Lemasle, E, Bastard, C, Tilly, H, Jardin, F

Get full text

125 FEBRILE EPISODES IN PATIENTS WITH MDS TREATED WITH AZACITIDINE. A THREE YEAR MONOCENTRIC RETROSPECTIVE STUDY by Stamatoullas, A, Rezine, I, Menard, A.L, Lanic, H, David, M, Daliphard, S, Penther, D, Cassuto, O, Lenain, P, Lepretre, S, Contentin, N, Lemasle, E, Cardinael, N, Fontura, M.L, Fronville, C, Jardin, F, Bastard, C, Tilly, H

Get full text

How to prevent relapse after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia and myelodysplastic syndrome by Yafour, N., Beckerich, F., Bulabois, C.E., Chevallier, P., Daguindau, E., Dumesnil, C., Guillaume, T., Huynh, A., Masouridi Levrat, S., Menard, A.L., Pautas, C., Poiré, X., Ravinet, A., Michallet, M., Bazarbachi, A.

“…Disease relapse remains the first cause of mortality of hematological malignancies after allogeneic hematopoietic stem cell transplantation (allo-HCT). The…”
Get full text

266 - Impact of Cytogenetics on Outcome after Allogeneic Transplantation for Myelodysplastic Syndrome or Post MDS Secundary Myeloid Leukemia by Menard, A.L., Marcq, B., Stamatoullas, A., Contentin, N., Lebreton, P., Rezine, I., Penther, D., Etancelin, P., Lepretre, S., Lenain, P., Lanic, H., Lemasle, E., Bastard, C., Tilly, H., Jardin, F.

Get full text